A detailed history of Greystone Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Greystone Financial Group, LLC holds 84,030 shares of ABT stock, worth $8.73 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares
84,030
Previous 79,317 5.94%
Holding current value
$8.73 Million
Previous $8.73 Million 9.39%
% of portfolio
1.95%
Previous 2.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$109.52 - $120.96 $516,167 - $570,084
4,713 Added 5.94%
84,030 $9.55 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $2.68 Million - $3.28 Million
29,666 Added 59.75%
79,317 $8.73 Million
Q3 2023

Nov 01, 2023

BUY
$95.53 - $114.62 $1.23 Million - $1.48 Million
12,873 Added 35.0%
49,651 $4.81 Million
Q2 2023

Jul 18, 2023

BUY
$100.78 - $112.29 $3.71 Million - $4.13 Million
36,778 New
36,778 $4.01 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Greystone Financial Group, LLC Portfolio

Follow Greystone Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greystone Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greystone Financial Group, LLC with notifications on news.